Publications by authors named "Nicholas J A Webb"

Claim this Profile
O
Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study.
David Kavanagh, Andrew S Bomback, Marina Vivarelli, Carla M Nester, Giuseppe Remuzzi, Nicholas J A Webb

Lancet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis using the United Kingdom RaDaR Registry.
Sherry Masoud, Katie Wong, David Pitcher, Lewis Downward, Clare Proudfoot, Nicholas J A Webb

Kidney Int· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor B as a therapeutic target for the treatment of complement-mediated diseases.
David Kavanagh, Jonathan Barratt, Anna Schubart, Nicholas J A Webb, Matthias Meier

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of immunoglobulin A nephropathy in the European Union and the impact of the COVID-19 pandemic: an estimation approach utilizing the kidney biopsy frequency.
Jocelyn Buisker, Sigrid Behr, Nadine Janet Kubesch, Moise E Turkson, Bart Maes, Nicholas J A Webb

Clin Kidney J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Transplantation in Children and Adolescents With C3 Glomerulopathy or Immune Complex Membranoproliferative Glomerulonephritis: An International Survey of Current Practice.
Christian Patry, Nicholas J A Webb, Matthias Meier, Lars Pape, Alexander Fichtner

Pediatr Transplant· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy.
Carla M Nester, Ute Eisenberger, Alexandre Karras, Moglie le Quintrec, Liz Lightstone, Nicholas J A Webb

Kidney Int Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney transplantation in children and adolescents with C3 glomerulopathy or immune complex membranoproliferative glomerulonephritis: a real-world study within the CERTAIN research network.
Christian Patry, Nicholas J A Webb, Manuel Feißt, Kai Krupka, Jan Becker

Pediatr Nephrol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iptacopan in Idiopathic Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study.
Marina Vivarelli, Andrew S Bomback, Matthias Meier, Yaqin Wang, Nicholas J A Webb

Kidney Int Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Edwin Wong, Carla Nester, Teresa Cavero, Alexandre Karras, Moglie Le Quintrec, Nicholas J A Webb

Kidney Int Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study.
Juliane Münch, Isabelle Sessler, Hans Martin Bosse, Manfred Wargenau, Janine D Dreesen, Nicholas J A Webb

Pharmaceutics· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Child and caregiver perspectives on access to psychosocial and educational support in pediatric chronic kidney disease: a focus group study.
Yifan Zhang, Talia Gutman, Allison Tong, Jonathan C Craig, Aditi Sinha, Nicholas J A Webb

Pediatr Nephrol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial.
Andrew S Bomback, David Kavanagh, Marina Vivarelli, Matthias Meier, Yaqin Wang, Nicholas J A Webb

Kidney Int Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients.
Elena Levtchenko, Aude Servais, Sally A Hulton, Gema Ariceta, Francesco Emma, Nicholas J A Webb

Clin Kidney J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis.
Nafsika Afentou, Emma Frew, Samir Mehta, Natalie J Ives, Rebecca L Woolley, Nicholas J A Webb

Pharmacoecon Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.
Martin T Christian, Nicholas J A Webb, Samir Mehta, Rebecca L Woolley, Nafsika Afentou

JAMA Pediatr· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of losartan and enalapril on serum uric acid and GFR in children with proteinuria.
Charlotte E Bryant, Azita Rajai, Nicholas J A Webb, Ronald J Hogg

Pediatr Nephrol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onabotulinum toxin-A versus extended release tolterodine in the management of idiopathic overactive bladder in children: A pilot randomised controlled trial (OVERT trial).
Michaela Brown, Paula R Williamson, Laura Sutton, Charlotte Melling, Malcolm Lewis, Nicholas J A Webb

J Pediatr Urol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing core outcome domains in pediatric kidney disease: report of the Standardized Outcomes in Nephrology-Children and Adolescents (SONG-KIDS) consensus workshops.
Camilla S Hanson, Jonathan C Craig, Charlotte Logeman, Aditi Sinha, Allison Dart, Nicholas J A Webb

Kidney Int· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of prolonged-release tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus - a Phase 2, open-label, single-arm, one-way crossover study.
Jacek Rubik, Dominique Debray, Deirdre Kelly, Franck Iserin, Nicholas J A Webb

Transpl Int· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eculizumab Safety: Five-Year Experience From the Global Atypical Hemolytic Uremic Syndrome Registry.
Eric Rondeau, Spero R Cataland, Imad Al-Dakkak, Benjamin Miller, Nicholas J A Webb

Kidney Int Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate- or prolonged-release tacrolimus.
Karel Vondrak, Francesco Parisi, Anil Dhawan, Ryszard Grenda, Nicholas J A Webb

Clin Transplant· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Important Outcomes for Young People With CKD and Their Caregivers: A Nominal Group Technique Study.
Camilla S Hanson, Talia Gutman, Jonathan C Craig, Sarah Bernays, Gayathri Raman, Nicholas J A Webb

Am J Kidney Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative pharmacokinetics of tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus to prolonged-release tacrolimus formulation.
Jacek Rubik, Dominique Debray, Franck Iserin, Karel Vondrak, Anne-Laure Sellier-Leclerc, Nicholas J A Webb

Pediatr Transplant· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Nicholas J A Webb, Rebecca L Woolley, Tosin Lambe, Emma Frew, Elizabeth A Brettell

BMJ· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of tacrolimus granules in pediatric de novo liver, kidney, and heart transplantation: The OPTION study.
Nicholas J A Webb, Ulrich Baumann, Manuela Camino, Esteban Frauca, Nasrullah Undre

Pediatr Transplant· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis